TLSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Tiziana Life Sciences Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 1, 2026
$1.01−0.04 (-3.81%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.94 (−48.21%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- EPS, diluted
- -$0.16
- Free cash flow
- -$12.87M
Eleven years at a glance
Fiscal years 2015 to 2025, USD
Operating income
-$21.13M
EPS, diluted
-$0.16
Free cash flow
-$12.87M
Reported period